Cytokine-Mediated Molecular Pathophysiology of Hidradenitis Suppurativa: A Narrative Review

被引:2
作者
Melchor, Julian [1 ]
Prajapati, Stuti [1 ]
Pichardo, Rita O. [2 ,3 ]
Feldman, Steven R. [1 ,2 ,3 ,4 ]
机构
[1] Wake Forest Univ, Sch Med, Dept Dermatol, Ctr Dermatol Res, Winston Salem, NC 27157 USA
[2] Wake Forest Sch Med, Dept Dermatol, Winston Salem, NC USA
[3] Wake Forest Univ, Sch Med, Dept Pathol, Winston Salem, NC USA
[4] Wake Forest Univ, Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC USA
关键词
Hidradenitis suppurativa; Cytokines; Biomarkers; Pathophysiology; Pathology; INFLAMMATION; PATHWAY; IL-10; SKIN;
D O I
10.1159/000536268
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory condition of the skin that mainly affects the apocrine gland-rich intertriginous areas. The disease manifests as painful nodules, abscesses, and pus-filled tunnels, which can severely impact patient's quality of life. While diagnosis is clinical, successful treatment options for this condition are limited. There has been an increase in research and clinical trials focusing on biomarkers and cytokines for clinical use. Understanding the potential biomarkers and cytokines implicated in HS pathogenesis may allow efficacious and safe treatment options. Summary: A literature review was conducted on nine biomarkers and cytokines. IL-1, IL-10, IL-17, IL-23, TNF-alpha, YKL-40, G-CSF, NOD2, and the complement system were identified due to their potential clinical utilization and pathophysiological involvement in HS. Key Messages: With further research expanding our understanding of the pathophysiology of HS and the roles these cytokines and biomarkers play, there is potential for utilization as diagnostic markers or development of antagonists against these specific agents for HS management.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 25 条
[1]   Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa [J].
Del Duca, Ester ;
Morelli, Paola ;
Bennardo, Luigi ;
Di Raimondo, Cosimo ;
Nistico, Steven Paul .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) :1-23
[2]   IL-17 in inflammatory skin diseases psoriasis and hidradenitis suppurativa [J].
Fletcher, J. M. ;
Moran, B. ;
Petrasca, A. ;
Smith, C. M. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2020, 201 (02) :121-134
[3]   NOD2 signalling in hidradenitis suppurativa [J].
Gambichler, T. ;
Hessam, S. ;
Skrygan, M. ;
Bakirtzi, M. ;
Kasakovski, D. ;
Bechara, F. G. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (08) :1488-1494
[4]   Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa [J].
Ghias, Mondana H. ;
Hyde, Michael J. ;
Tomalin, Lewis E. ;
Morgan, B. Paul ;
Alavi, Afsaneh ;
Lowes, Michelle A. ;
Piguet, Vincent .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (03) :531-+
[5]   Novel variants of MEFV and NOD2 genes in familial hidradenitis suppurativa: A case report [J].
Jfri, Abdulhadi ;
Litvinov, Ivan, V ;
Netchiporouk, Elena ;
O'Brien, Elizabeth .
SAGE OPEN MEDICAL CASE REPORTS, 2020, 8
[6]   Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis? [J].
Kanni, T. ;
Zenker, O. ;
Habel, M. ;
Riedemann, N. ;
Giamarellos-Bourboulis, E. J. .
BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (02) :413-419
[7]   Treatment Outcomes of IL-17 Inhibitors in Hidradenitis Suppurativa: A Systematic Review [J].
Kashetsky, Nadia ;
Mufti, Asfandyar ;
Alabdulrazzaq, Shaikhah ;
Lytvyn, Yuliya ;
Sachdeva, Muskaan ;
Rahat, Abdullah ;
Yeung, Jensen .
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2022, 26 (01) :79-86
[8]   Analysis of the Complement System in the Clinical Immunology Laboratory [J].
Ling, Morris ;
Murali, Mandakolathur .
CLINICS IN LABORATORY MEDICINE, 2019, 39 (04) :579-+
[9]   The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside [J].
Liu, Taoming ;
Li, Sheng ;
Ying, Shuni ;
Tang, Shunli ;
Ding, Yuwei ;
Li, Yali ;
Qiao, Jianjun ;
Fang, Hong .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[10]   Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents [J].
Matusiak, Lukasz ;
Szczech, Justyna ;
Bieniek, Andrzej ;
Nowicka-Suszko, Danuta ;
Szepietowski, Jacek C. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (04) :670-675